Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
Countries citing papers authored by Gerald P. Bodey
Since
Specialization
Citations
This map shows the geographic impact of Gerald P. Bodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald P. Bodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald P. Bodey more than expected).
This network shows the impact of papers produced by Gerald P. Bodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald P. Bodey. The network helps show where Gerald P. Bodey may publish in the future.
Co-authorship network of co-authors of Gerald P. Bodey
This figure shows the co-authorship network connecting the top 25 collaborators of Gerald P. Bodey.
A scholar is included among the top collaborators of Gerald P. Bodey based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Gerald P. Bodey. Gerald P. Bodey is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Elting, Linda S., et al.. (1988). Human/Computer Interfaces: A Randomized Trial of Data Entry and Editing Formats. PubMed Central. 459–462.1 indexed citations
7.
Burgess, M. A., et al.. (1982). Continuous five-day infusion of vindesine in the treatment of metastatic malignant melanoma. Proceedings of the American Association for Cancer Research. 23.1 indexed citations
8.
Keating, Michael J., K. B. McCredie, Gerald P. Bodey, & Emil J. Freireich. (1981). Short-term sequential (S-TS) chemotherapy in young patients with acute myelogenous leukemia (AML). Proceedings of the American Association for Cancer Research. 22.2 indexed citations
9.
Cabanillas, Fernando, Gerald P. Bodey, M. A. Burgess, & Emil J. Freireich. (1979). Results of a phase II study of maytansine in patients with breast carcinoma and melanoma.. PubMed. 63(3). 507–9.12 indexed citations
10.
Bedikian, Agop Y., et al.. (1979). Chemotherapy for sarcoma of the stomach.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(3). 411–4.4 indexed citations
11.
Valdivieso, Manuel, Gerald P. Bodey, & E. J. Freireich. (1978). Initial clinical studies of gallium (GA) nitrate (N) NSC 15200. Proceedings of the American Association for Cancer Research. 19.1 indexed citations
12.
Legha, Sewa S., Jordan U. Gutterman, Stephen W. Hall, et al.. (1978). Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3712–6.63 indexed citations
13.
Barlogie, Barthel, et al.. (1978). In vivo perturbation of human marrow cell cycle progression by ifosfamide.. PubMed. 38(8). 2209–15.8 indexed citations
14.
Murphy, William K., R. B. Livingston, E. A. Gehan, & Gerald P. Bodey. (1977). Sequential chemotherapy in the treatment of cancer of the head and neck. Proceedings of the American Association for Cancer Research. 18.2 indexed citations
15.
Rodríguez, V., Gerald P. Bodey, & Emil J. Freireich. (1977). Increased remission rate and prolongation of survival in patients with soft tissue sarcomas treated with intensive chemotherapy on a protected environment prophylactic antibiotic program (PEPA). Proceedings of the American Association for Cancer Research. 18.6 indexed citations
16.
Benjamin, Robert S., M. A. Burgess, & Gerald P. Bodey. (1977). A phase I II study of adriamycin DNA complex (A DNA). Proceedings of the American Association for Cancer Research. 18.2 indexed citations
17.
Rodríguez, V., Gerald P. Bodey, Eugene M. McKelvey, & E. J. Freireich. (1976). Combination chemotherapy (CHOP BLEO) of advanced diffuse histiocytic lymphoma (DHL). Proceedings of the American Association for Cancer Research. 17.2 indexed citations
18.
Gottlieb, Jeffrey A., E. J. Freireich, & Gerald P. Bodey. (1975). Preliminary clinical evaluation of piperazinedione (P), a new crystalline antibiotic. Proceedings of the American Association for Cancer Research. 16(66).5 indexed citations
19.
Rodríguez, V., Gerald P. Bodey, K. B. McCredie, & E. J. Freireich. (1974). Protected environments (PE) and prophylactic antibiotics in remission induction therapy of adults with acute leukemia. Proceedings of the American Association for Cancer Research. 15.1 indexed citations
20.
Livingston, R. B., Gerald P. Bodey, Jeffrey A. Gottlieb, & Emil Frei. (1973). Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.. PubMed. 57(2). 219–24.31 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.